Vimarsana
Biggest News Aggregation in the World

Page 6 - Anders Segerstr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Anders Segerstr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Anders Segerstr Today - Breaking & Trending Today

iZafe Group: iZafe's Subsidiary Pilloxa Signs a Cooperation Agreement with Chiesi in Germany with a Value of SEK 1 million - Vimarsana News

iZafe Group: iZafe's Subsidiary Pilloxa Signs a Cooperation Agreement with Chiesi in Germany with a Value of SEK 1 million

STOCKHOLM, SWEDEN / ACCESSWIRE / March 7, 2023 / iZafe Group (STO:IZAFE-B.ST) iZafe Group (publ.) hereby announces that its wholly owned subsidiary Pilloxa AB is expanding its digital support for patients

iZafe Group Signs Agreement with New Partner in the United Kingdom Worth at Least SEK 18.7 Million - Vimarsana News

iZafe Group Signs Agreement with New Partner in the United Kingdom Worth at Least SEK 18.7 Million

STOCKHOLM, SWEDEN / ACCESSWIRE / March 2, 2023 / iZafe Group (STO:IZAFE-B) iZafe Group AB ("iZafe Group") hereby announces that the company has signed an exclusive collaboration agreement with Targeted

iZafe Group Announces Exclusive Agreement to sell 1,000 Dosell Annually - Vimarsana News

iZafe Group Announces Exclusive Agreement to sell 1,000 Dosell Annually

STOCKHOLM, SE / ACCESSWIRE / February 27, 2023 / iZafe Group (STO:IZAFE-B) iZafe Group AB ("iZafe Group") announce that it has signed an exclusive partnership agreement with IVE Ventures ("IVE") for the

The Subscription Price for Exercise of Warrants of Series TO13B in iZafe Group AB has been Set at SEK 0.20 Per Share of Series B, and the Exercise Period Begins Tomorrow February 23 - Vimarsana News

The Subscription Price for Exercise of Warrants of Series TO13B in iZafe Group AB has been Set at SEK 0.20 Per Share of Series B, and the Exercise Period Begins Tomorrow February 23

STOCKHOLM, SE / ACCESSWIRE / February 22, 2023 / iZafe Group (STO:IZAFE-B) In November 2022 iZafe Group AB ("iZafe" or the "Company") acquired Pilloxa AB and, in connection with the acquisition, carried

iZafe Group: iZafe has been Granted a New Patent for Safer Medication Handling at Home - Vimarsana News

iZafe Group: iZafe has been Granted a New Patent for Safer Medication Handling at Home

STOCKHOLM, SWEDEN / ACCESSWIRE / January 25, 2023 / iZafe Group (STO:IZAFE-B) iZafe Group AB (publ.) announces that the Swedish Patent and Registration Office (PRV) intends to grant another patent application